| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |